Stock ZLAB ZAI LAB LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Zai Lab Limited

Equities

ZLAB

US98887Q1040

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 15:12:27 30/04/2024 BST 		5-day change 1st Jan Change
16.54 USD +2.57% Intraday chart for Zai Lab Limited +9.64% -39.34%
04-17 Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading MT
04-11 Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024 MT

Business Summary

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Number of employees: 2,175

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Therapies
100.0 %
215 100.0 % 267 100.0 % +24.03%

Sales per region

USD in Million2022Weight2023Weight Delta
Greater China and United States
100.0 %
215 100.0 % 267 100.0 % +24.03%

Managers

Managers TitleAgeSince
Ying Du CEO
 Chief Executive Officer 59 31/03/14
Ya jing Chen DFI
 Director of Finance/CFO 56 31/08/21
Joshua Smiley PSD
 President 54 31/07/22
Peter Huang CTO
 Chief Tech/Sci/R&D Officer - 07/11/22
Ann Beasley CMP
 Compliance Officer - 31/10/20
James Yan CTO
 Chief Tech/Sci/R&D Officer 60 31/03/20
Ning Xu CTO
 Chief Tech/Sci/R&D Officer 59 31/12/13
Lina Zhang SAM
 Sales & Marketing - -
Li Ni Ou Yang SEC
 Corporate Secretary - 26/06/22
F. Edmondson LAW
 General Counsel 58 06/08/20

Members of the board

Members of the board TitleAgeSince
John D. Diekman BRD
 Director/Board Member 81 31/12/16
Peter Wirth BRD
 Director/Board Member 73 31/12/16
Lonnie Moulder BRD
 Director/Board Member 66 31/12/18
Wing Yu Leung BRD
 Director/Board Member 53 31/07/14
William Lis BRD
 Director/Board Member 60 30/09/18
Kai Xian Chen BRD
 Director/Board Member 79 13/08/18
Ying Du CEO
 Chief Executive Officer 59 31/03/14
Richard Gaynor BRD
 Director/Board Member 74 18/11/21
Scott Morrison BRD
 Director/Board Member 66 12/10/21
Michel Vounatsos BRD
 Director/Board Member 62 06/01/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 977,151,270 879,293,014 ( 89.99 %) 4,912,200 ( 0.5027 %) 89.99 %

Shareholders

NameEquities%Valuation
Qiming Venture Partners Ltd.
7.986 %
79,229,320 7.986 % 131 M $
Wellington Management Co. LLP
6.129 %
60,805,022 6.129 % 100 M $
Wellington Management International Ltd.
2.041 %
20,249,300 2.041 % 33 M $
UBS Asset Management Switzerland AG
1.908 %
18,926,266 1.908 % 31 M $
Bosera Asset Management Co., Ltd.
0.7694 %
7,633,300 0.7694 % 13 M $
Capital Research & Management Co. (World Investors)
0.5470 %
5,426,290 0.5470 % 9 M $
Peter Wirth
0.3646 %
3,616,660 0.3646 % 6 M $
Fidelity Management & Research (Hong Kong) Ltd.
0.3093 %
3,068,300 0.3093 % 5 M $
HuaAn Fund Management Co., Ltd.
0.2538 %
2,518,100 0.2538 % 4 M $
Fidelity Management & Research (Japan) Ltd.
0.2472 %
2,452,600 0.2472 % 4 M $
NameEquities%Valuation
Wellington Management Co. LLP
5.379 %
5,336,457 5.379 % 85 M $
Capital Research & Management Co. (World Investors)
5.260 %
5,218,843 5.260 % 84 M $
Janus Henderson Investors US LLC
4.073 %
4,040,282 4.073 % 65 M $
T. Rowe Price International Ltd.
2.726 %
2,704,455 2.726 % 43 M $
Woodline Partners LP
2.035 %
2,018,527 2.035 % 32 M $
Invesco Advisers, Inc.
1.909 %
1,893,529 1.909 % 30 M $
Viking Global Investors LP
1.884 %
1,869,283 1.884 % 30 M $
Segantii Capital Management Ltd.
1.701 %
1,687,569 1.701 % 27 M $
BAMCO, Inc.
1.503 %
1,490,874 1.503 % 24 M $
Fidelity Management & Research Co. LLC
1.247 %
1,236,927 1.247 % 20 M $

Company contact information

Zai Lab Ltd.

Jinchuang Plaza Building 1, 4/F

201210, Shanghai

+86 21 6163 2588

http://www.zailaboratory.com
address Zai Lab Limited(ZLAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Ratings for Zai Lab Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.12 USD
Average target price
52.5 USD
Spread / Average Target
+225.71%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
ZAI LAB LIMITED Stock Zai Lab Limited
-39.34% 1.59B
CSL LIMITED Stock CSL Limited
-3.45% 87.17B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.97% 40.1B
BIOGEN INC. Stock Biogen Inc.
-16.98% 31.38B
UCB Stock UCB
+57.98% 25.12B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.87% 15.59B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-8.82% 12B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-41.58% 11.8B
INCYTE CORPORATION Stock Incyte Corporation
-15.27% 11.8B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.89% 8.81B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. ZLAB Stock
  4. Company Zai Lab Limited